All Stories

  1. Distribution, severity, and management of joint pain in patients with acromegaly

    Article • European Journal of Endocrinology, March 2026, Oxford University Press (OUP)

    Dr Robert D Murray

  2. Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey study

    Article • BMJ Open, February 2026, BMJ

    Dr Robert D Murray

  3. Clinical and Genetic Spectrum of Large AIP Deletions

    Article • Human Mutation, January 2026, Wiley

    Dr Robert D Murray

  4. Mineralocorticoid effects of fludrocortisone and hydrocortisone in primary adrenal insufficiency: EU-AIR patient data

    Article • Journal of Endocrinological Investigation, September 2025, Springer Science + Business Media

    Dr Robert D Murray

  5. Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research

    Article • Andrology, May 2025, Wiley

    Dr Leen Antonio, Dr Robert D Murray

  6. Conservatively managed non-functioning pituitary macroadenomas—cohort study from the UK Non-functioning Pituitary Adenoma Consortium

    Article • European Journal of Endocrinology, April 2025, Oxford University Press (OUP)

    Dr Robert D Murray

  7. Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group

    Article • European Journal of Endocrinology, March 2025, Oxford University Press (OUP)

    Dr Robert D Murray

  8. The Cost of Adrenal Insufficiency in England—Analysis of NHS HES Data

    Article • Clinical Endocrinology, February 2025, Wiley

    Dr Robert D Murray

  9. APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health – study protocol paper for a phase III multicentre, open-label randomised controlled trial

    Article • BMJ Open, February 2025, BMJ

    Dr Robert D Murray

  10. Risk of diabetes in childhood and young adult cancer survivors

    Article • Diabetes Care, January 2025, American Diabetes Association

    Kirsten Cromie, Dr Robert D Murray

  11. Are Oral Somatostatin Receptor Ligands Moving Closer to Becoming a Reality?

    Article • Clinical Endocrinology, December 2024, Wiley

    Dr Robert D Murray

  12. Safety and Effectiveness of a Biosimilar Recombinant Growth Hormone in Adults with Growth Hormone Deficiency: Analysis of Final Data from PATRO Adults, an International Post-Marketing Surveillance Study

    Article • Drug Design Development and Therapy, December 2024, Taylor & Francis

    Dr Robert D Murray

  13. Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency

    Article • Pituitary, November 2023, Springer Science + Business Media

    Dr Robert D Murray

  14. The impact of radiotherapy on the hypothalamo-pituitary axis: old vs new radiotherapy techniques

    Article • Endocrine Connections, July 2023, Bioscientifica

    Dr Robert D Murray

  15. Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium

    Article • European Journal of Endocrinology, June 2023, Oxford University Press (OUP)

    Dr Robert D Murray

  16. A study of acromegaly-associated headache with somatostatin analgesia

    Article • Endocrine Related Cancer, March 2023, Bioscientifica

    Dr Robert D Murray

  17. Oral Octreotide Capsules and Paltusotine in Management of Acromegaly

    Article • touchREVIEWS in Endocrinology, January 2023, Touch Digital Media, Ltd.

    Dr Robert D Murray

  18. Rivaroxaban: A Rare Cause of Spontaneous Bilateral Adrenal Haematomas

    Article • Chonnam Medical Journal, January 2023, XMLink

    Dr Robert D Murray

  19. Paltusotine, a novel oral somatostatin receptor ligand in the management of acromegaly

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2022, Endocrine Society

    Dr Robert D Murray

  20. Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance

    Article • The Lancet Diabetes & Endocrinology, August 2022, Elsevier

    Dr Robert D Murray

  21. Characterisation of the onset and severity of adrenal and thyroid dysfunction associated with CTLA4-related hypophysitis

    Article • European Journal of Endocrinology, January 2022, Oxford University Press (OUP)

    Dr Robert D Murray

  22. Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors

    Article • Endocrine Reviews, November 2021, Endocrine Society

    Dr Robert D Murray

  23. Adjuvant Rituximab – exploratory trial in young people with Graves’ disease

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2021, Endocrine Society

    Dr Robert D Murray

  24. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group

    Article • The Lancet Diabetes & Endocrinology, September 2021, Elsevier

    Dr Robert D Murray

  25. ChAdOx1 SARS‐CoV‐2 vaccination: A putative precipitant of adrenal crises

    Article • Clinical Endocrinology, August 2021, Wiley

    Dr Robert D Murray

  26. Outcomes of 756 patients with differentiated thyroid cancer and excellent response to treatment: An evidence‐based paradigm for long‐term surveillance strategies

    Article • Clinical Endocrinology, July 2021, Wiley

    Dr Robert D Murray

  27. Post-operative volumes following endoscopic surgery for non-functioning pituitary macroadenomas are predictive of further intervention, but not endocrine outcomes

    Article • BMC Endocrine Disorders, June 2021, Springer Science + Business Media

    Dr Robert D Murray

  28. Characterization of patients with adrenal insufficiency and frequent adrenal crises

    Article • European Journal of Endocrinology, June 2021, Oxford University Press (OUP)

    Dr Robert D Murray

  29. Evaluation of cardiovascular risk factors in long-term survivors of adult- and childhood-onset brain tumours: a pilot study

    Article • Endocrine Connections, May 2021, Bioscientifica

    Dr Robert D Murray

  30. Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults)

    Article • Pituitary, March 2021, Springer Science + Business Media

    Dr Robert D Murray

  31. Interpretation of the endocrinology of hospital inpatients

    Article • British Journal of Hospital Medicine, January 2021, Mark Allen Group

    Dr Robert D Murray

  32. The severity of obstructive sleep apnoea does not

    Article • Clinical Endocrinology, October 2020, Wiley

    Dr Robert D Murray

  33. Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs

    Article • Expert Opinion on Drug Safety, October 2020, Taylor & Francis

    Dr Robert D Murray

  34. Management of persistent acromegaly following primary therapy: The current landscape in the UK

    Article • Endocrinology Diabetes & Metabolism, June 2020, Wiley

    Dr Robert D Murray

  35. Performance of the unilateral AV/IVC index in primary hyperaldosteronism subtype prediction: A validation study in a single tertiary centre

    Article • Clinical Endocrinology, May 2020, Wiley

    Dr Robert D Murray

  36. Prothrombotic fibrin network characteristics in patients with acromegaly: a novel mechanism for vascular complications

    Article • European Journal of Endocrinology, May 2020, Oxford University Press (OUP)

    Dr Robert D Murray

  37. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism

    Article • Clinical Endocrinology, January 2020, Wiley

    Dr Robert D Murray

  38. Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from the PATRO Adults study

    Article • Therapeutic Advances in Endocrinology and Metabolism, January 2020, SAGE Publications

    Dr Robert D Murray

  39. No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study

    Article • BMC Endocrine Disorders, December 2019, Springer Science + Business Media

    Dr Robert D Murray

  40. Outcomes of Patients with Nelson’s Syndrome after Primary Treatment: A Multicenter Study from 13 UK Pituitary Centers

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2019, Endocrine Society

    Dr Robert D Murray

  41. Is Chemotherapy Implicated in the Development of Hypopituitarism in Childhood Cancer Survivors?

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2019, Endocrine Society

    Dr Robert D Murray

  42. When Can We Discharge Differentiated Thyroid Cancer Patients Who Present With High-Risk Disease and Subsequently Have an Excellent Response to Treatment?

    Article • Clinical Oncology, October 2019, Elsevier

    Dr Robert D Murray

  43. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study

    Article • Thyroid, June 2019, Mary Ann Liebert Inc

    Dr Ilaria IM Muller, Professor Bijay Vaidya, Salman Razvi, Dr Robert D Murray

  44. Can We Discharge Dynamically Risk-Stratified Low-Risk (Excellent Response to Treatment) Thyroid Cancer Patients After 5 Years of Follow-Up?

    Article • Clinical Oncology, April 2019, Elsevier

    Dr Robert D Murray

  45. Hypothalamo‐pituitary axis irradiation dose thresholds for development of hypopituitarism in adult‐onset gliomas

    Article • Clinical Endocrinology, March 2019, Wiley

    Dr Robert D Murray

  46. Glucocorticoid management of adrenal insufficiency in the United Kingdom: assessment using real-world data

    Article • Endocrine Connections, January 2019, Bioscientifica

    Dr Robert D Murray

  47. Management of glucocorticoids following adrenalectomy for ACTH-independent Cushing's syndrome

    Article • Clinical Endocrinology, September 2018, Wiley

    Dr Robert D Murray

  48. Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations

    Article • Clinical Endocrinology, April 2018, Wiley

    Professor Andrea M. Isidori, Dr Robert D Murray

  49. Late-onset X-linked adrenal hypoplasia (DAX-1, NR0B1): two new adult-onset cases from a single center

    Article • Pituitary, July 2017, Springer Science + Business Media

    Dr Robert D Murray

  50. Endemic goitre and hypothyroidism in an adult female patient dependent on total parenteral nutrition

    Article • Endocrinology Diabetes and Metabolism Case Reports, June 2017, Bioscientifica

    Dr Robert D Murray

  51. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study

    Article • Clinical Endocrinology, April 2017, Wiley

    Dr Robert D Murray

  52. In Response to: Prednisolone Replacement Therapy Mimics the Circadian Rhythm More Closely than Other Glucocorticoids

    Article • The Journal of Applied Laboratory Medicine, February 2017, AACC

    Dr Robert D Murray

  53. Diagnostic challenges and management of a patient with acromegaly due to ectopic growth hormone-releasing hormone secretion from a bronchial carcinoid tumour

    Article • Endocrinology Diabetes and Metabolism Case Reports, January 2017, Bioscientifica

    Marta Korbonits, Dr Robert D Murray

  54. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR

    Article • Clinical Endocrinology, December 2016, Wiley

    Dr Robert D Murray

  55. Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency

    Article • Endocrine Connections, November 2016, Bioscientifica

    Dr Robert D Murray

  56. A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2016, Endocrine Society

    Dr Robert D Murray, Professor Bijay Vaidya

  57. Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours

    Article • Clinical Endocrinology, November 2015, Wiley

    Dr Robert D Murray

  58. Response to ‘How we define hyponatremia?’

    Article • European Journal of Clinical Investigation, September 2015, Wiley

    Dr Robert D Murray

  59. The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure

    Article • August 2015, Bioscientifica

    Dr Robert D Murray

  60. The diagnosis and management of inpatient hyponatraemia and SIADH

    Article • European Journal of Clinical Investigation, June 2015, Wiley

    Dr Robert D Murray

  61. Endocrine sequelae beyond 10 years in survivors of medulloblastoma

    Article • Clinical Endocrinology, June 2015, Wiley

    Dr Robert D Murray

  62. The effects of pituitary and thyroid disorders on haemostasis: potential clinical implications

    Article • Clinical Endocrinology, March 2015, Wiley

    Dr Robert D Murray

  63. Lanreotide autogel in acromegaly – a decade on

    Article • Expert Opinion on Pharmacotherapy, October 2014, Informa Healthcare

    Dr Robert D Murray

  64. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy

    Article • BMC Endocrine Disorders, May 2014, Springer Science + Business Media

    Dr Robert D Murray

  65. Atypical Presentation of Riedel’s Thyroiditis: Multifocal Nodular Fibrosis and Resolution with Levothyroxine

    Article • European Thyroid Journal, January 2012, Karger Publishers

    Dr Robert D Murray

  66. Serum vascular endothelial growth factor (VEGF) is elevated in GH deficient adults

    Article • Growth Hormone & IGF Research, April 2011, Elsevier

    Dr Robert D Murray

  67. Partial Growth Hormone Deficiency is Associated With an Adverse Cardiovascular Risk Profile and Increased Carotid Intima-Medial Thickness.

    Article • Clinical Endocrinology, December 2009, Wiley

    Dr Robert D Murray

  68. Current therapy and drug pipeline for the treatment of patients with acromegaly

    Article • Advances in Therapy, April 2009, Springer Science + Business Media

    Dr Robert D Murray

  69. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset

    Article • Clinical Endocrinology, January 2009, Wiley

    Dr Robert D Murray

  70. Hypogonadotropic hypogonadism: a consequence of Chiari-I malformation

    Article • Pituitary, September 2008, Springer Science + Business Media

    Dr Robert D Murray

  71. A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2008, Endocrine Society

    Dr Robert D Murray

  72. Resolution of secondary amenorrhoea following withdrawal of dihydocodeine

    Article • Clinical Endocrinology, April 2008, Wiley

    Dr Robert D Murray

  73. The Diagnosis of Partial Growth Hormone Deficiency in Adults with a Putative Insult to the Hypothalamo-Pituitary Axis

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2007, Endocrine Society

    Dr Robert D Murray

  74. The Impact of Short-Term Fasting on the Dynamics of 24-Hour Growth Hormone (GH) Secretion in Patients with Severe Radiation-Induced GH Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2006, Endocrine Society

    Dr Robert D Murray

  75. A Densitometric and Morphometric Analysis of the Skeleton in Adults with Varying Degrees of Growth Hormone Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2006, Endocrine Society

    Dr Robert D Murray

  76. Quality of Life in Adult Growth Hormone Deficiency

    Article • January 2006, Elsevier

    Dr Robert D Murray

  77. The Phenotype of Adults with Partial Growth Hormone Deficiency

    Article • Hormone Research in Paediatrics, November 2005, Karger Publishers

    Dr Robert D Murray

  78. Insulin sensitivity is impaired in adults with varying degrees of GH deficiency

    Article • Clinical Endocrinology, February 2005, Wiley

    Dr Robert D Murray

  79. Impact of Growth Hormone Status on Body Composition and the Skeleton

    Article • Hormone Research in Paediatrics, November 2004, Karger Publishers

    Dr Robert D Murray

  80. Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis

    Article • Journal of Clinical Investigation, August 2004, American Society for Clinical Investigation

    Dr Robert D Murray

  81. The Novel Somatostatin Ligand (SOM230) Regulates Human and Rat Anterior Pituitary Hormone Secretion

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2004, Endocrine Society

    Dr Robert D Murray

  82. Growth Hormone Replacement Decreases Plasma Levels of Matrix Metalloproteinases (2 and 9) and Vascular Endothelial Growth Factor in Growth Hormone-Deficient Individuals

    Article • Circulation, May 2004, Wolters Kluwer Health

    Dr Robert D Murray

  83. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status

    Article • Clinical Endocrinology, April 2004, Wiley

    Dr Robert D Murray

  84. Adults with Partial Growth Hormone Deficiency Have an Adverse Body Composition

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2004, Endocrine Society

    Dr Robert D Murray

  85. Low Bone Mass Is an Infrequent Feature of the Adult Growth Hormone Deficiency Syndrome in Middle-Age Adults and the Elderly

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2004, Endocrine Society

    Dr Robert D Murray

  86. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis

    Article • Clinical Endocrinology, December 2003, Wiley

    Dr Robert D Murray

  87. Adult growth hormone replacement: current understanding

    Article • Current Opinion in Pharmacology, December 2003, Elsevier

    Dr Robert D Murray

  88. Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement

    Article • Molecular Genetics and Metabolism, November 2003, Elsevier

    Dr Robert D Murray

  89. Adult Growth Hormone Replacement: Lessons Learned and Future Direction

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2002, Endocrine Society

    Dr Robert D Murray

  90. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults

    Article • Clinical Endocrinology, September 2002, Wiley

    Dr Robert D Murray

  91. Timing of onset of growth hormone deficiency is a major influence on insulin-like growth factor I status in adult life

    Article • Clinical Endocrinology, July 2002, Wiley

    Dr Robert D Murray

  92. Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes

    Article • Diabetologia, May 2002, Springer Science + Business Media

    Dr Robert D Murray

  93. Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome

    Article • Clinical Endocrinology, April 2002, Wiley

    Dr Robert D Murray

  94. Spinal irradiation impairs the osteo-anabolic effects of low-dose GH replacement in adults with childhood-onset GH deficiency

    Article • Clinical Endocrinology, February 2002, Wiley

    Dr Robert D Murray

  95. Differential Effects of GH Replacement on the Components of the Leptin System in GH-Deficient Individuals

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2002, Endocrine Society

    Dr Robert D Murray

  96. GH-Deficient Survivors of Childhood Cancer: GH Replacement during Adult Life

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2002, Endocrine Society

    Dr Robert D Murray

  97. The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients

    Article • Clinical Endocrinology, January 2001, Wiley

    Dr Robert D Murray

  98. Survivors of child-hood cancer: long-term endocrine and metabolic problems dwarf the growth disturbance.

    Article • Rehabilitation Oncology, January 2001, Wolters Kluwer Health

    Dr Robert D Murray

  99. Growth hormone: current and future therapeutic applications

    Article • Expert Opinion on Pharmacotherapy, July 2000, Informa Healthcare

    Dr Robert D Murray

  100. Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency

    Article • Clinical Endocrinology, May 2000, Wiley

    Dr Robert D Murray

  101. Clinical presentation of PCOS following development of an insulinoma: Case Report

    Article • Human Reproduction, January 2000, Oxford University Press (OUP)

    Dr Robert D Murray

  102. Survivors of childhood cancer: long-term edocrine and metabolic problems dwarf the growth distrubance

    Article • Acta Paediatrica, December 1999, Wiley

    Dr Robert D Murray

  103. Influences on quality of life in GH deficient adults and their effect on response to treatment

    Article • Clinical Endocrinology, November 1999, Wiley

    Dr Robert D Murray

  104. Gonadotrophin-releasing hormone analogues: a novel treatment for premenstrual asthma

    Article • European Respiratory Journal, October 1999, European Respiratory Society (ERS)

    Dr Robert D Murray

  105. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults

    Article • Clinical Endocrinology, June 1999, Wiley

    Dr Robert D Murray